Thermo Fisher Scientific reports record performance in Q1 2012

Thermo Fisher Scientific has reported record-breaking financial results for the first three months of 2012.

The life science firm's revenues surged by 14 percent year over year to $3.1 billion (1.91 billion pounds), while adjusted earnings per share grew by 27 percent to a new benchmark figure of $1.17.

During the quarter, new ion chromatography, gas chromatography, mass spectrometry and handheld instruments for life sciences and applied markets were introduced, including the Myecl Imager and the PikoReal PCR System.

In addition, the company was able to expand its presence in a number of key emerging markets, including the opening of a new customer demonstration and training centre in South Korea.

Marc Casper, president and chief executive officer of Thermo Fisher Scientific, said: "Our revenue growth was fuelled largely by demand for analytical instruments across a broad base of customers, as well as ongoing strength in our biopharma services business."

Earlier this month, the company introduced its new Thermo Scientific Nalgene Rapid-Flow Filter, a device that enables accelerated filtration of cell culture media.